# The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis

> **NCT00503698** · PHASE3 · TERMINATED · sponsor: **Novo Nordisk A/S** · enrollment: 712 (actual)

## Conditions studied

- Chronic Kidney Disease
- End-Stage Renal Disease

## Interventions

- **DRUG:** somatropin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00503698
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-07
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 712 (ACTUAL)
- **Why stopped:** See termination reason in detailed description
- **Last updated:** 2017-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00503698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00503698, "The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT00503698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*